Samuel M Behar Selected Research

Biomarkers (Surrogate Marker)

11/2016

IL-21 signaling is essential for optimal host resistance against Mycobacterium tuberculosis infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Samuel M Behar Research Topics

Disease

34	Tuberculosis (Tuberculoses) 06/2022 - 11/2002
31	Infections 06/2022 - 07/2003
5	Necrosis 01/2013 - 11/2008
4	Granuloma 10/2022 - 05/2015
3	Inflammation (Inflammations) 02/2014 - 10/2010
2	Persistent Infection 03/2016 - 05/2015
2	Latent Tuberculosis 03/2009 - 09/2008
1	Atrophy 01/2021
1	Hyperglycemia 11/2014
1	Starvation 12/2013
1	Pulmonary Tuberculosis 01/2013
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2013
1	Pneumonia (Pneumonitis) 10/2011
1	Genital Diseases 05/2011
1	Abetalipoproteinemia (Bassen Kornzweig Syndrome) 08/2010
1	Rheumatoid Arthritis 03/2010
1	Rheumatic Diseases (Rheumatism) 03/2009
1	Lyme Disease (Disease, Lyme) 09/2006
1	Neoplasms (Cancer) 11/2003
1	Communicable Diseases (Infectious Diseases) 11/2002
1	Autoimmune Diseases (Autoimmune Disease) 06/2002

Drug/Important Bio-Agent (IBA)

16	VaccinesIBA 10/2022 - 09/2005
11	AntigensIBA 01/2020 - 12/2004
9	CytokinesIBA 01/2021 - 12/2008
8	LipidsIBA 01/2016 - 11/2003
6	AerosolsIBA 02/2016 - 11/2008
4	Interferon-gamma (Interferon, gamma)IBA 01/2021 - 09/2008
4	InterferonsIBA 01/2021 - 10/2011
4	Proteins (Proteins, Gene)FDA Link 01/2016 - 06/2002
3	Peptides (Polypeptides)IBA 01/2020 - 09/2005
3	EpitopesIBA 01/2020 - 12/2004
3	EicosanoidsIBA 01/2016 - 01/2010
3	ProstaglandinsIBA 08/2010 - 11/2008
3	Prostaglandins EIBA 01/2010 - 11/2008
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 01/2020
2	Interleukin-2 (IL2)IBA 01/2021 - 03/2016
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 10/2017 - 01/2014
2	lipoxin A4IBA 01/2013 - 11/2008
2	Dinoprostone (PGE2)FDA Link 01/2013 - 11/2008
2	LigandsIBA 10/2010 - 11/2002
2	alpha-galactosylceramideIBA 09/2010 - 11/2002
1	RNA (Ribonucleic Acid)IBA 10/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	Caspase 3 (Caspase-3)IBA 01/2021
1	GlucocorticoidsIBA 01/2021
1	Recombinant ProteinsIBA 01/2020
1	PPAR gammaIBA 10/2017
1	Neutralizing AntibodiesIBA 10/2017
1	interleukin-21 (interleukin 21)IBA 11/2016
1	Biomarkers (Surrogate Marker)IBA 11/2016
1	Interleukin-10 (Interleukin 10)IBA 03/2016
1	Interleukin-27 (Interleukin 27)IBA 02/2016
1	Cytokine Receptors (Cytokine Receptor)IBA 02/2016
1	Interleukin-12 (IL 12)IBA 02/2016
1	ProteomeIBA 01/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2016
1	BCG Vaccine FDA Link 01/2016
1	Antimicrobial PeptidesIBA 01/2016
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2015
1	Immunodominant EpitopesIBA 05/2015
1	p38 Mitogen-Activated Protein KinasesIBA 11/2014
1	ChromatinIBA 11/2014
1	Receptor for Advanced Glycation End ProductsIBA 11/2014
1	Tryptophan (L-Tryptophan)FDA Link 12/2013
1	Pharmaceutical PreparationsIBA 01/2013
1	invariant chain (Ii-Key)IBA 08/2011
1	Lysosomal Membrane ProteinsIBA 08/2011
1	Carrier Proteins (Binding Protein)IBA 05/2011
1	Glycoproteins (Glycoprotein)IBA 05/2011
1	Viral VaccinesIBA 05/2011
1	Galactosylceramides (Galactocerebrosides)IBA 09/2010
1	microsomal triglyceride transfer proteinIBA 08/2010
1	LipoxinsIBA 08/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2009
1	Tumor Necrosis Factor InhibitorsIBA 03/2009
1	PerforinIBA 12/2008
1	Prostaglandin-E SynthasesIBA 11/2008
1	Biological ProductsIBA 10/2008
1	SolutionsIBA 09/2008
1	GoldIBA 09/2008
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2006
1	DiglyceridesIBA 09/2006
1	GlycosphingolipidsIBA 09/2006
1	GlycolipidsIBA 09/2006
1	IntegrinsIBA 04/2006
1	Lymphocyte Function-Associated Antigen-1 (LFA-1)IBA 04/2006
1	Cell ExtractsIBA 11/2003
1	Toll-Like Receptors (Toll-Like Receptor)IBA 07/2003

Therapy/Procedure

3	Therapeutics 06/2022 - 11/2002
1	Lasers (Laser) 01/2016
1	Immunotherapy 10/2008